J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades

(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on use of the drug, which it warned could be misused and abused.

FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo

The approval of nasal spray esketamine marks the first new type of treatment for depression in more than 30 years and has raised hopes for its relatively fast action and ability to treat some otherwise unreachable patients.

Esketamine would be sold under the brand name Spravato and is a chemical mirror image of anesthetic ketamine, which is also abused as a recreational party drug and goes by the street nickname “Special K”. To prevent abuse, patients must take the drug in a doctor’s office or medical facility and cannot take it home.

Currently available anti-depressants such as Eli Lilly and Co’s Prozac work on neurotransmitters like serotonin and norepinephrine, but most drugs take at least four weeks to show effect and fail to produce an adequate response in about 30 percent to 40 percent of patients with major depressive disorder (MDD).

“Spravato has the potential to change the treatment paradigm and offer new hope to the estimated one-third of people with major depressive disorder who have not responded to existing therapies,” said Mathai Mammen, global head of J&J’s Janssen Research & Development.

Spravato has been touted as an asset with blockbuster potential and is expected to improve investor sentiment toward the growth prospects of J&J’s pharma unit Janssen, as its top-selling rheumatoid arthritis drug Remicade faces increased competition from cheaper biosimilars.

The treatment carries a boxed warning – FDA’s harshest – flagging the risk for sedation and difficulty with attention, judgment and thinking, abuse and misuse, and suicidal thoughts after administration of the drug.

Spravato is absorbed by the lining of the nasal passages and into the blood stream and will be used along with a newly prescribed oral antidepressant, Johnson & Johnson said in a statement here

During clinical trials, Spravato was found to relieve depression symptoms within 24 hours in some patients, said Janssen spokesman Greg Panico.

The approval comes after an FDA advisory panel in February voted heavily in favor of the drug esketamine, saying its benefits outweighed the risks.

However, the panel members echoed concerns raised by FDA staffers regarding the increased risk of sedation, dissociation and higher blood pressure observed in the study.

The drug is also being tested in patients with depression who are at a high risk of committing suicide.

Recent research shows that depression involves deterioration of the quality and number of nerve cell connections in areas of the brain related to mood. J&J’s drug helps restore these nerve cell connections in the brain, leading to an improvement in depression symptoms, according to the company. Over 300 million people globally live with major depressive disorders, and the incidence of attempted suicide in people with this condition is about 20-fold higher than that among those without the disorder.

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Cynthia Osterman and Lisa Shumaker

Source

more recommended stories

  • Senator Gillibrand wants insurance to pay for fertility treatments

    WASHINGTON (Reuters) – U.S. Democratic presidential.

  • Hundreds rally at U.S. Supreme Court, calling state abortion bans as step backward

    WASHINGTON (Reuters) – Abortion-rights campaigners, including.

  • French court says doctors must resume life support for paralyzed patient

    STRASBOURG, France (Reuters) – A French.

  • Missouri follows Alabama by passing restrictive abortion bill

    (Reuters) – Missouri lawmakers passed a.

  • Too much screen time tied to school problems even in little kids

    (Reuters Health) – Kindergarteners who get.

  • Smokers have higher risk for multiple strokes

    (Reuters Health) – Smokers who have.

  • Missouri assembly passes restrictive abortion bill, days after Alabama

    (Reuters) – The lower house of.

  • Missouri Senate passes bill to ban abortions after eight weeks

    (Reuters) – Missouri’s Senate passed a.

  • Alabama governor signs strictest U.S. abortion ban into law

    (Reuters) – Alabama’s governor signed a.

  • Alabama Senate bans nearly all abortions, including rape cases

    (Reuters) – Alabama’s state Senate passed.

  • Israel regulator warns of medical cannabis bubble, eyes Australia pact

    JERUSALEM (Reuters) – Medical cannabis could.

  • U.S. measles outbreak grows with 75 new cases, mostly in New York

    (Reuters) – U.S. health authorities recorded.

  • Teva Pharm CFO says company did not conspire to fix prices

    FILE PHOTO: The logo of Teva.

  • U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit

    WASHINGTON (Reuters) – U.S. states filed.

  • Exclusive: Philip Morris suspends social media campaign after Reuters exposes young ‘influencers’

    (Reuters) – Cigarette maker Philip Morris.

  • Hong Kong reports African swine fever case

    HONG KONG (Reuters) – Hong Kong.

  • Alabama Senate delays vote on strict anti-abortion bill

    (Reuters) – Alabama’s state Senate on.

  • Denver votes to become first U.S. city to decriminalize ‘magic mushrooms’

    Psilocybin or “magic mushrooms” are seen.

  • AstraZeneca-Daiichi Sankyo breast cancer drug shows promise

    The company logo for pharmaceutical company.

  • Denver to vote on decriminalizing ‘magic mushrooms’

    FILE PHOTO: Boxes containing magic mushrooms.

  • Trans teens face higher sexual assault risk when schools restrict bathrooms

    (Reuters Health) – Transgender adolescents may.

  • U.S. doctors use medical records to fight measles outbreak

    CHICAGO (Reuters) – U.S. doctors are.

  • UK’s Vectura wins patent infringement case against GlaxoSmithKline in U.S

    (Reuters) – British drugmaker Vectura Group.

  • Tyson Foods recalls almost 12 million pounds of chicken strips over contamination fears

    (Reuters) – Tyson Foods Inc significantly.

  • Monstrous rumors stoke hostility to Pakistan’s anti-polio drive

    PESHAWAR, Pakistan (Reuters) – His bearded.

  • U.S. health agency finalizes conscience and religious freedom rule

    WASHINGTON (Reuters) – The U.S. Department.

  • Medication use drops when local drugstores close

    (Reuters Health) – People are less.

  • EPA says popular weed killer glyphosate is not a carcinogen

    CHICAGO (Reuters) – The U.S. Environmental.

  • Novartis’s Sandoz strikes deal for biosimilar of Herceptin

    FILE PHOTO: Swiss drugmaker Novartis’ logo.

  • U.S. measles outbreak triggers quarantine at two Los Angeles universities

    LOS ANGELES (Reuters) – A nationwide.

  • U.S. measles outbreak raises questions about immunity in adults

    (Reuters) – Adults in the United.

  • FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug

    (Reuters) – The U.S. Food and.